A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC Read more about A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC
Clinical Information and Biospecimen Collection From Patients With Recurrent or Stage IV Breast Cancer Read more about Clinical Information and Biospecimen Collection From Patients With Recurrent or Stage IV Breast Cancer
Study of REGN5678 (Anti-PSMAxCD28) With Cemiplimab (Anti-PD-1) in Patients With Metastatic Castration-resistant Prostate Cancer Read more about Study of REGN5678 (Anti-PSMAxCD28) With Cemiplimab (Anti-PD-1) in Patients With Metastatic Castration-resistant Prostate Cancer
Vancomycin Powder and Dilute Povidone Iodine Lavage for Infection Prophylaxis in High Risk Total Joint Arthroplasty Read more about Vancomycin Powder and Dilute Povidone Iodine Lavage for Infection Prophylaxis in High Risk Total Joint Arthroplasty
Suvorexant and Sleep/Delirium in ICU Patients Read more about Suvorexant and Sleep/Delirium in ICU Patients
Study of Radiation Therapy Followed by Atezolizumab in Stage II or III Non-small Cell Lung Cancer Patients Read more about Study of Radiation Therapy Followed by Atezolizumab in Stage II or III Non-small Cell Lung Cancer Patients
ACTIV-5 / Big Effect Trial (BET-B) for the Treatment of COVID-19 Read more about ACTIV-5 / Big Effect Trial (BET-B) for the Treatment of COVID-19
Study to Evaluate the Safety and Antitumor Activity of CX-2009 Monotherapy and in Combination With CX-072 in Advanced Breast Cancer Read more about Study to Evaluate the Safety and Antitumor Activity of CX-2009 Monotherapy and in Combination With CX-072 in Advanced Breast Cancer
Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (LOGOS) Read more about Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (LOGOS)
Study of JTX 8064, as Monotherapy and in Combination With a PD-1 Inhibitor, in Adult Subjects With Advanced Refractory Solid Tumors Read more about Study of JTX 8064, as Monotherapy and in Combination With a PD-1 Inhibitor, in Adult Subjects With Advanced Refractory Solid Tumors